Local Anesthesia and Tuberculin Skin Test in Infants and Children
Information source: Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Tuberculosis
Intervention: lidocaine / Prilocaine (Drug)
Phase: N/A
Status: Not yet recruiting
Sponsored by: Assistance Publique - Hôpitaux de Paris Official(s) and/or principal investigator(s): Nicole Beydon, MD, Principal Investigator, Affiliation: APHP
Overall contact: Nicole Beydon, MD, Phone: +33 140 032 000, Email: nicole.beydon@rdb.aphp.fr
Summary
The use of local anaesthesia efficiently reduces pain due to needle puncture. However, when
tuberculin skin test is performed it is the skin reaction to tuberculin injection that is
studied. It is a quantitative skin reaction measured in millimiters. From the study of
literature it is not known whether local anaesthetic modify skin reaction to tuberculin.
Therefore, before recommending the use local anaesthesia for tuberculin intradermal
injection we have to rule out a potential effect of local anaesthetic on the result of the
test. This is particularly important in children, since there are more sensitive to pain
than adults
Clinical Details
Official title: Local Anesthesia Effect on Tuberculin Skin Test Results in Infants and Children
Study design: Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind, Primary Purpose: Treatment
Primary outcome: Measurement of tuberculin skin tests reaction performed with and withoutlocal anaesthesia, in a child (intra subject reproducibility)
Secondary outcome: influence of local anaesthesia use, on tuberculin skin test interpretationbetween observer reproducibility pain evaluation in child over 5 years of age between tuberculin skin tests performed with and without local anaesthesia relationship between local anaesthesia use and failure to perform a correct intradermal injection local tolerance to lidocaine / prilocaine
Eligibility
Minimum age: 1 Month.
Maximum age: 15 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
hospitalized or non hospitalized infant or child (3 months-15 years)requiring a tuberculin
skin test, in our hospital. hospitalized 1 to 3 months old infants requiring a tuberculin
skin test, in our hospital.
-
Exclusion Criteria:
- child with contra indication to the use of Lidocaine / prilocaine
- child with evolutive dermatitis on forearms
- premature or newborn (less than 1 month of age)
- infants (1 - 24 months of age)who has yet received repeated local anaesthesia (at
least 2)during the 24 previous hours
- infants (1 - 24 months of age)who is treated with a drug that could enhance the risk
of methhaemoglobinemia
- child with previous evere local reaction to tuberculin injection
(necrosis,ulceration)
- child with history of tuberculosis disease
- child with hepatic failure
- parents or the child himself if lod enough, have not given their agreement for the
study
Locations and Contacts
Nicole Beydon, MD, Phone: +33 140 032 000, Email: nicole.beydon@rdb.aphp.fr
Robert Debré Hospital, Paris 75019, France; Active, not recruiting
Additional Information
Last updated: March 31, 2006
|